Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

VLDL and LDL Subfractions Enhance the Risk Stratification of Individuals Who Underwent Epstein-Barr Virus-Based Screening for Nasopharyngeal Carcinoma: A Multicenter Cohort Study.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2024
Same author

SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers.

Clinical and translational medicine·2024
Same author

The phospholipid flippase ATP9A enhances macropinocytosis to promote nutrient starvation tolerance in hepatocellular carcinoma.

The Journal of pathology·2023
Same author

Targeted Wolfram-Doped Polypyrrole for Photonic Hyperthermia-Synergized Radiotherapy.

ACS applied materials & interfaces·2022
Same author

COMMD10 inhibits tumor progression and induces apoptosis by blocking NF-κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma.

Clinical and translational medicine·2021

Related Experiment Video

Updated: Jul 1, 2025

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

57.7K

Copper and Copper Complexes in Tumor Therapy.

Yingqiao Wang1, Tingxi Tang1, Yi Yuan1

  • 1Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Chemmedchem
|March 5, 2024
PubMed
Summary

Copper (Cu) is vital for cell function. Imbalances in copper homeostasis are linked to cancer, making copper-targeting drugs a promising anticancer therapy strategy.

Keywords:
Inorganic Chemistrybiological and Medicinal Chemistrycancer treatmentcopper complexescopper metabolism

More Related Videos

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

1.3K
Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
08:11

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria

Published on: May 16, 2025

115

Related Experiment Videos

Last Updated: Jul 1, 2025

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

57.7K
Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

1.3K
Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
08:11

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria

Published on: May 16, 2025

115

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Copper (Cu) is an essential trace element involved in numerous physiological processes.
  • Cellular copper homeostasis is critical; disruptions can lead to toxicity and cell death, impacting cancer progression.
  • Targeting copper regulation presents a novel strategy for anticancer drug development.

Purpose of the Study:

  • To review the role of copper in cancer.
  • To explore therapeutic strategies targeting copper homeostasis, including chelators, ionophores, and complexes.
  • To highlight recent advancements in copper-based cancer therapy.

Main Methods:

  • Literature review of studies on copper's role in cancer.
  • Analysis of research on copper homeostasis modulators (chelators, ionophores).
  • Examination of studies involving novel copper complexes for cancer treatment.

Main Results:

  • Copper dysregulation is implicated in various cancer types.
  • Copper chelators, ionophores, and complexes show potential in preclinical cancer models.
  • Emerging research indicates promise for copper complexes in cancer therapy.

Conclusions:

  • Copper homeostasis is a significant factor in cancer biology.
  • Targeting cellular copper levels offers a viable therapeutic avenue for cancer treatment.
  • Further research into copper-based drugs, particularly complexes, is warranted for clinical application.